These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36378958)

  • 1. On-demand cell-autonomous gene therapy for brain circuit disorders.
    Qiu Y; O'Neill N; Maffei B; Zourray C; Almacellas-Barbanoj A; Carpenter JC; Jones SP; Leite M; Turner TJ; Moreira FC; Snowball A; Shekh-Ahmad T; Magloire V; Barral S; Kurian MA; Walker MC; Schorge S; Kullmann DM; Lignani G
    Science; 2022 Nov; 378(6619):523-532. PubMed ID: 36378958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epilepsy Gene Therapy Using an Engineered Potassium Channel.
    Snowball A; Chabrol E; Wykes RC; Shekh-Ahmad T; Cornford JH; Lieb A; Hughes MP; Massaro G; Rahim AA; Hashemi KS; Kullmann DM; Walker MC; Schorge S
    J Neurosci; 2019 Apr; 39(16):3159-3169. PubMed ID: 30755487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kv1.1 and Kv1.2: similar channels, different seizure models.
    Robbins CA; Tempel BL
    Epilepsia; 2012 Jun; 53 Suppl 1():134-41. PubMed ID: 22612818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. K
    Thouta S; Zhang Y; Garcia E; Snutch TP
    Sci Rep; 2021 Jul; 11(1):15180. PubMed ID: 34312446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous seizures in Kcna1-null mice lacking voltage-gated Kv1.1 channels activate Fos expression in select limbic circuits.
    Gautier NM; Glasscock E
    J Neurochem; 2015 Oct; 135(1):157-64. PubMed ID: 26112121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy for epilepsy.
    Staley K
    Science; 2022 Nov; 378(6619):471-472. PubMed ID: 36378973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo CRISPRa decreases seizures and rescues cognitive deficits in a rodent model of epilepsy.
    Colasante G; Qiu Y; Massimino L; Di Berardino C; Cornford JH; Snowball A; Weston M; Jones SP; Giannelli S; Lieb A; Schorge S; Kullmann DM; Broccoli V; Lignani G
    Brain; 2020 Mar; 143(3):891-905. PubMed ID: 32129831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuron-specific Kv1.1 deficiency is sufficient to cause epilepsy, premature death, and cardiorespiratory dysregulation.
    Trosclair K; Dhaibar HA; Gautier NM; Mishra V; Glasscock E
    Neurobiol Dis; 2020 Apr; 137():104759. PubMed ID: 31978607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuregulin 1 regulates excitability of fast-spiking neurons through Kv1.1 and acts in epilepsy.
    Li KX; Lu YM; Xu ZH; Zhang J; Zhu JM; Zhang JM; Cao SX; Chen XJ; Chen Z; Luo JH; Duan S; Li XM
    Nat Neurosci; 2011 Dec; 15(2):267-73. PubMed ID: 22158511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seizures and reduced life span in mice lacking the potassium channel subunit Kv1.2, but hypoexcitability and enlarged Kv1 currents in auditory neurons.
    Brew HM; Gittelman JX; Silverstein RS; Hanks TD; Demas VP; Robinson LC; Robbins CA; McKee-Johnson J; Chiu SY; Messing A; Tempel BL
    J Neurophysiol; 2007 Sep; 98(3):1501-25. PubMed ID: 17634333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetics of KCNQ channel activation in 2 potassium channelopathy mouse models of epilepsy.
    Vanhoof-Villalba SL; Gautier NM; Mishra V; Glasscock E
    Epilepsia; 2018 Feb; 59(2):358-368. PubMed ID: 29265344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural consequences of Kcna1 gene deletion and transfer in the mouse hippocampus.
    Wenzel HJ; Vacher H; Clark E; Trimmer JS; Lee AL; Sapolsky RM; Tempel BL; Schwartzkroin PA
    Epilepsia; 2007 Nov; 48(11):2023-46. PubMed ID: 17651419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kv1.1 channel subunits in the control of neurocardiac function.
    Glasscock E
    Channels (Austin); 2019 Dec; 13(1):299-307. PubMed ID: 31250689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental seizure susceptibility of kv1.1 potassium channel knockout mice.
    Rho JM; Szot P; Tempel BL; Schwartzkroin PA
    Dev Neurosci; 1999 Nov; 21(3-5):320-7. PubMed ID: 10575255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of seizures by transplantation of cortical GABAergic interneuron precursors into Kv1.1 mutant mice.
    Baraban SC; Southwell DG; Estrada RC; Jones DL; Sebe JY; Alfaro-Cervello C; García-Verdugo JM; Rubenstein JL; Alvarez-Buylla A
    Proc Natl Acad Sci U S A; 2009 Sep; 106(36):15472-7. PubMed ID: 19706400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optogenetic and potassium channel gene therapy in a rodent model of focal neocortical epilepsy.
    Wykes RC; Heeroma JH; Mantoan L; Zheng K; MacDonald DC; Deisseroth K; Hashemi KS; Walker MC; Schorge S; Kullmann DM
    Sci Transl Med; 2012 Nov; 4(161):161ra152. PubMed ID: 23147003
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LGI1 downregulation increases neuronal circuit excitability.
    Lugarà E; Kaushik R; Leite M; Chabrol E; Dityatev A; Lignani G; Walker MC
    Epilepsia; 2020 Dec; 61(12):2836-2846. PubMed ID: 33104247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potassium dynamics and seizures: Why is potassium ictogenic?
    de Curtis M; Uva L; Gnatkovsky V; Librizzi L
    Epilepsy Res; 2018 Jul; 143():50-59. PubMed ID: 29660559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ERG3 potassium channel-mediated suppression of neuronal intrinsic excitability and prevention of seizure generation in mice.
    Xiao K; Sun Z; Jin X; Ma W; Song Y; Lai S; Chen Q; Fan M; Zhang J; Yue W; Huang Z
    J Physiol; 2018 Oct; 596(19):4729-4752. PubMed ID: 30016551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potassium channels as prominent targets and tools for the treatment of epilepsy.
    Nikitin ES; Vinogradova LV
    Expert Opin Ther Targets; 2021 Mar; 25(3):223-235. PubMed ID: 33754930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.